MoneyWorks4Me

Lupin informs about press release

25 Jan 2021 Evaluate

Lupin has informed that it has enclosed a Press Release as regards receipt of USFDA approval for the Company's Sevelamer Carbonate Tablets, 800 mg, to market a generic equivalent of Renvela Tablets, 800 mg, of Genzyme Corporation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.75
Dr. Reddys Labs. 1321.00
Cipla 1364.90
Lupin 1958.30
Zydus Lifesciences 1171.35
View more..